(Q35037912)

5 August 2017

1 reference

title

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria (English)

1 reference

idiopathic inflammatory myopathy

5 August 2017

1 reference

1 reference

Frank L Mastaglia

1

1 reference

5 August 2017

Beverley A Phillips

series ordinal

2

1 reference

5 August 2017

language of work or name

1 reference

1 November 2002

1 reference

Rheumatic Diseases Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

723-741

1 reference

Polymyositis and dermatomyositis (first of two parts)

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

The epidemiology of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

The incidence of juvenile dermatomyositis: results from a nation-wide study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Prevalence of sporadic inclusion body myositis in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Metabolic and mitochondrial myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

1 reference

7 January 2021

Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Racial differences in scleroderma among women in Michigan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Muscle disease in progressive systemic sclerosis. diagnostic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Amyopathic dermatomyositis in Hong Kong -- association with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Inclusion body myositis: clinical and pathological boundaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Idiopathic orbital myositis: report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

1 reference

7 January 2021

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Update on the genetics of the idiopathic inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

HLA associations with inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Evidence for seasonal variation in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Occurrence of polymyositis in the county of Gävleborg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Incidence of rare systemic rheumatic and connective tissue diseases in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900021-2

7 January 2021

10.1016/S0889-857X(02)00021-2

Identifiers

DOI

1 reference

5 August 2017

1 reference